The evidence in favor of adult COVID-19 vaccines is overwhelming. In August, an unvaccinated adult was six times more likely than a vaccinated adult to test positive for COVID-19 and 11 times more likely to die from it.
According to information published on Tuesday by the Food and Drug Administration and the CDC, the tale isn’t so easy for children aged 5 to 11.
The FDA’s advisory group agreed that the benefits of immunization outweigh the risks of this aged institution after hours of hearing from Pfizer BioNTech experts and law enforcement personnel.
A similar discussion will take place during the CDC Advisory Board’s daily meeting next week. If FDA and CDC officials close the center, the vaccination should be available to children aged 5 to 11 next week as soon as the center reopens.
How does COVID-19 affect me?
In this way, moms and dads can quickly face choices: they alternately carry a small risk that their toddlers get seriously ill from COVID-19 or alleged images.
It is possible to protect young people by wearing the inside of a sports mask and immunizing the lives of adults without vaccination, said CDC director Rochelle Walensky.
In one view, up to 42% of adolescents of this age are inflamed by the onset of a pandemic, with more than 8,000 hospitalizations and less than 100 deaths. Cases of adolescents increased this summer due to delta fluctuations, but now it seems that adolescents are less ill with these fluctuations than others.
Also, in the last 12 months, the importance of keeping young people in college has become apparent. Vaccination of young people has definitely reduced the number of university closures and has kept more than one million young people out of school. This autumn.
Benefits of COVID-19 vaccine
Based on an investigation of roughly 2,500 children, the Pfizer-BioNTechs COVID-19 vaccine is very effective in children aged 5 to 11 years old, blocking over 90% of illnesses.
The vaccine appears to be safe and causes the greatest side effects of short-term injection site pain, headache, malaise, and mild fever by adolescent and adult-use specialists.
What are the more or less rare secondary consequences?
Pfizer’s BioNTechs protection trial protected about 5,000 children, which is insufficient to reveal rare secondary results.
The best problem The effect of volume facets is known as myocarditis. This is an inflammation of the coronary myocardium and may be due to COVID-19. Post-vaccination myocarditis was especially seen in adolescents and adolescents, usually men, after the second dose of the vaccine.
For every 1 million people aged 16 and 17 who were vaccinated, 69 developed the condition, while only 1 million men were 40 years old. No one died.
Myocarditis is large and not uncommon, usually found in older young adults and adolescents, and decreases in the age group of 5-11 years, but it is currently unknown whether it is genuine due to the vaccine.
What are the approximate long-term results and benefits?
Like adults, vaccination of children no longer produces long-term fitness results that are no longer visible in the first few weeks after injection. In one of all studies, children were observed for several months on average. Among others, only a few weeks so far.
The Pfizer-BioNTech vaccine, like Moderna, activates the framework to provide harmless proteins detected in the bed of viruses that cause COVID-19. This allows the immune system to understand and respond to the entire virus.
This production is no longer closed for a long time, and the messenger RNA used to deliver the vaccine no longer retains or invades the mobile nucleus in which the DNA is stored, so the necessary adjustments are made to prevent mobile activity.
It’s uncertain how long the COVID-19 vaccination will protect babies aged 5 to 11 years from contamination, or whether booster immunization is required, as it is with the adult vaccine.
Dr. Paul Offit admits that he always needs additional information, but he believes that this case is sufficient to evaluate whether immunization is required.
“For me, I think it’s enough to vote in favor,” said Offit, an infectious disease specialist at Philadelphia Children’s Hospital.
Infection Price: According to the FDA’s assessment of vaccine protection and efficacy in adolescents, profits outweigh the risks until infection rates fall below this 5% at peak September.
Infectious disease prices are currently declining somewhere in the country, but whether they could rise again in winter (respiratory viruses such as COVID-19 usually tend to multiply in winter), and It is unknown if it is new. You will see a version aimed at making vaccination more important.
Previous infections: Babies who have already been infected with COVID-19 are more resistant to the virus and are less likely to develop a serious disease.
Vaccines, in general, offer more reliable safety than contamination. Adult studies have indicated that contamination may provide a greater level of safety for mutants.
Infant Vulnerability: Children who are immunosuppressed or who have physical problems such as weight problems or metabolic disorders are at increased risk in extreme cases.
COVID-19 hospitalized youngsters were already in good physical shape in two-thirds of cases. Vaccination can help babies in this class more than healthy babies.
In addition, CDC epidemiologist Fiona Havers told the committee on Tuesday that colored children (black, brown, or Native American) were hospitalized three times at the expense of white children.
Perhaps because of family exposure and personal health hazards, they will benefit most from vaccination.
“The most endangered children want to be vaccinated,” he says. James Hill dress, Commission Member, President, and CEO of Meharry Medical College in Nashville, Tennessee.
Mr. Hildress voted for most of the committee to support the vaccine, but he said he had a hard time making a decision because he didn’t want all the children to be vaccinated.
“In some approaches, we are vaccination of children to protect adults, and that should be another way,” he said.